AAAAAA

   
Results: 1-7 |
Results: 7
PHASE-I TRIAL OF SEQUENTIAL HIGH-DOSE CHEMOTHERAPY WITH ESCALATING DOSE PACLITAXEL, MELPHALAN, AND CYCLOPHOSPHAMIDE, THIOTEPA, AND CARBOPLATIN WITH PERIPHERAL-BLOOD PROGENITOR SUPPORT IN WOMEN WITH RESPONDING METASTATIC BREAST-CANCER
Authors: VAHDAT LT PAPADOPOULOS K BALMACEDA C MCGOVERN T DUNLEAVY J KAUFMAN E FUNG B GARRETT T SAVAGE D TIERSTEN A AYELLO J BAGIELLA E HEITJAN D ANTMAN K HESDORFFER C
Citation: Lt. Vahdat et al., PHASE-I TRIAL OF SEQUENTIAL HIGH-DOSE CHEMOTHERAPY WITH ESCALATING DOSE PACLITAXEL, MELPHALAN, AND CYCLOPHOSPHAMIDE, THIOTEPA, AND CARBOPLATIN WITH PERIPHERAL-BLOOD PROGENITOR SUPPORT IN WOMEN WITH RESPONDING METASTATIC BREAST-CANCER, Clinical cancer research, 4(7), 1998, pp. 1689-1695
INFLUENCE OF INFLAMMATORY BOWEL-DISEASE ON THE ABILITY OF PATIENTS TOTOLERATE SYSTEMIC FLUOROURACIL-BASED CHEMOTHERAPY
Authors: TIERSTEN A SALTZ LB
Citation: A. Tiersten et Lb. Saltz, INFLUENCE OF INFLAMMATORY BOWEL-DISEASE ON THE ABILITY OF PATIENTS TOTOLERATE SYSTEMIC FLUOROURACIL-BASED CHEMOTHERAPY, Journal of clinical oncology, 14(7), 1996, pp. 2043-2046
RAPIDLY CYCLED COURSES OF HIGH-DOSE ALKYLATING-AGENTS SUPPORTED BY FILGRASTIM AND PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH METASTATIC BREAST-CANCER
Authors: VAHDAT L RAPTIS G FENNELLY D HAMILTON N REICH L TIERSTEN A HARRISON M HUDIS C MOORE M YAO TJ NORTON L CROWN J
Citation: L. Vahdat et al., RAPIDLY CYCLED COURSES OF HIGH-DOSE ALKYLATING-AGENTS SUPPORTED BY FILGRASTIM AND PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH METASTATIC BREAST-CANCER, Clinical cancer research, 1(11), 1995, pp. 1267-1273
ACUTE HYPERTENSIVE CRISIS FOLLOWING OCTREOTIDE ADMINISTRATION IN A PATIENT WITH MALIGNANT PHEOCHROMOCYTOMA
Authors: SALTZ LB TIERSTEN A HASSAN BN GROEGER JS
Citation: Lb. Saltz et al., ACUTE HYPERTENSIVE CRISIS FOLLOWING OCTREOTIDE ADMINISTRATION IN A PATIENT WITH MALIGNANT PHEOCHROMOCYTOMA, Oncology Reports, 2(6), 1995, pp. 1129-1130
PHASE-II TRIAL OF PACLITAXEL BY 3-HOUR INFUSION AS INITIAL AND SALVAGE CHEMOTHERAPY FOR METASTATIC BREAST-CANCER
Authors: SEIDMAN AD TIERSTEN A HUDIS C GOLLUB M BARRETT S YAO TJ LEPORE J GILEWSKI T CURRIE V CROWN J HAKES T BASELGA J SKLARIN N MOYNIHAN ME TONG W EGORIN M KEARNS C SPRIGGS D NORTON L
Citation: Ad. Seidman et al., PHASE-II TRIAL OF PACLITAXEL BY 3-HOUR INFUSION AS INITIAL AND SALVAGE CHEMOTHERAPY FOR METASTATIC BREAST-CANCER, Journal of clinical oncology, 13(10), 1995, pp. 2575-2581
RAPID HEMATOLOGIC RECOVERY FOLLOWING CD34-BLOOD PROGENITOR-CELL (PBPC) PLUS FILGRASTIM (G) RESCUE OF SEQUENTIAL HIGH-DOSE CHEMOTHERAPY (HDC) IN PATIENTS (PTS) WITH METASTATIC BREAST-CANCER (MBC)( SELECTED VERSUS UNSELECTED PERIPHERAL)
Authors: RAPTIS G TIERSTEN A SHAPIRO F SCHNEIDER J HAMILTON N REICH L WUEST D GUCCIARDO A QUIGUYAN L GILEWSKI T BASELGA J THEODOULOU M HUDIS C SURBONE A MOORE M CROWN J NORTON L
Citation: G. Raptis et al., RAPID HEMATOLOGIC RECOVERY FOLLOWING CD34-BLOOD PROGENITOR-CELL (PBPC) PLUS FILGRASTIM (G) RESCUE OF SEQUENTIAL HIGH-DOSE CHEMOTHERAPY (HDC) IN PATIENTS (PTS) WITH METASTATIC BREAST-CANCER (MBC)( SELECTED VERSUS UNSELECTED PERIPHERAL), Blood, 86(10), 1995, pp. 1601-1601
LONG-TERM HEMATOPOIESIS IS NOT AFFECTED BY RAPID-CYCLING OF SEQUENTIAL HIGH-DOSE CHEMOTHERAPY (HDC) PRIOR TO FULL HEMATOLOGIC RECOVERY
Authors: TIERSTEN A RAPTIS G CROWN J VAHDAT L HAMILTON N REICH L DAMASKOS P NORTON L
Citation: A. Tiersten et al., LONG-TERM HEMATOPOIESIS IS NOT AFFECTED BY RAPID-CYCLING OF SEQUENTIAL HIGH-DOSE CHEMOTHERAPY (HDC) PRIOR TO FULL HEMATOLOGIC RECOVERY, Blood, 84(10), 1994, pp. 10000210-10000210
Risultati: 1-7 |